Progress in the treatment of multiple sclerosis.docVIP

 PAGE \* MERGEFORMAT 5 Progress in the treatment of multiple sclerosis [Abstract] Multiple Sclerosis (Multiple Sclerosis, MS) is a central nervous system inflammatory demyelinating disease, cellular immunity and humoral immunity to participate in the occurrence of the disease. No effects of treatment, treatment aimed at the termination of acute attacks, prevention of recurrence and disease modification and symptomatic treatment. Treatment of choice is based on different clinical types and different periods of the disease. [Keywords:] multiple sclerosis; treatment Therapeutic aclvances of the multiple sclerosis [Abstract] Multiple sclerosis (MS) is a central nervous system inflammatory demyelinating disease. Abnormalities of humoral immunity and cellular immunity may be its mechanisms. There is no specific remedy yet. But we still have some treatments to halt the progression, some of acute exacerbations and some symptomatic therapies. Treatment selection is based on the different clinical type and different duration of MS. [Keywords:] multiple sclerosis; treatment Multiple Sclerosis (Multiple Sclerosis, MS) is a central nervous system inflammatory demyelinating disease, showed a worldwide distribution, is estimated that there are around one million young MS patients [1]. Etiology and pathogenesis of MS has not clearly defined, is now considered by the T-cell-mediated immune response, viral infection, caused by genetic factors. Cell-mediated immunity and humoral immunity by the joint participation led to the central nervous system white matter injury of the main diseases, there is no effect of treatment, the therapeutic aim is to terminate the acute attack, prevention of recurrence and disease modification and symptomatic treatment. Clinical classification of its main relapsing-remitting type (relapsing remitting Multiple Sclerosis RRMS), expressed as relapsing-remitting turn, the condition was no significant progress; primary progressive (primary progres